Schematic illustration of HAase nanogel-armed CAR-T cell strategy (IMAGE)
Caption
Upon systemic administration, H-NGs utilize the tumor trafficking of CAR-T cells to penetrate tumor tissues, bypassing the tumor vasculature system (Step 1). As the result, H-NGs on the cellular surface are stimulated by high concentrations of ROS in the TME (Step 2). Then, the HAase released from H-NGs effectively degrades the condensed tumor extracellular matrix (step 3). The degradation of the tumor matrix in solid tumors results in an increased infiltration of CAR-T cells (step 4) and a heightened antitumor response (step 5).
Credit
Nano Research, Tsinghua University Press
Usage Restrictions
News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.
License
Original content